-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Bellicum Pharmaceuticals, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2019 to Q3 2023.
- Bellicum Pharmaceuticals, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 30.9M shares, a 0.24% increase year-over-year.
- Bellicum Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 30.8M shares, a 168% increase from 2021.
- Bellicum Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 11.5M shares, a 99.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)